Skip to Content

Amarillo Biosciences Inc

Rating as of

Company Profile

Business Description

Amarillo Biosciences Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low dose oral form.

4134 Business Park Drive
Amarillo, TX, 79110-4225
T +1 806 376-1741
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2020
Fiscal Year End Dec 31, 2020
Stock Type Distressed
Employees 4